Fonte: Bioorganic and Medicinal Chemistry. Unidades: FCF, ICB, PRÓ-G
Assuntos: CITOTOXICIDADE IMUNOLÓGICA, ENZIMAS, FARMACOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, APOPTOSE, PROLIFERAÇÃO CELULAR
ABNT
TAVARES, Maurício Temotheo et al. Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors. Bioorganic and Medicinal Chemistry, v. 35, p. 1-42 art. 116085, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bmc.2021.116085. Acesso em: 10 nov. 2024.APA
Tavares, M. T., Almeida, L. C. de, Kronenberger, T., Ferreira, G. M., Divitiis, T. F. de, Toledo, M. F. Z. J., et al. (2021). Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors. Bioorganic and Medicinal Chemistry, 35, 1-42 art. 116085. doi:10.1016/j.bmc.2021.116085NLM
Tavares MT, Almeida LC de, Kronenberger T, Ferreira GM, Divitiis TF de, Toledo MFZJ, Hassimotto NMA, Machado Neto JA, Costa-Lotufo LV, Parise Filho R. Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors [Internet]. Bioorganic and Medicinal Chemistry. 2021 ; 35 1-42 art. 116085.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.bmc.2021.116085Vancouver
Tavares MT, Almeida LC de, Kronenberger T, Ferreira GM, Divitiis TF de, Toledo MFZJ, Hassimotto NMA, Machado Neto JA, Costa-Lotufo LV, Parise Filho R. Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors [Internet]. Bioorganic and Medicinal Chemistry. 2021 ; 35 1-42 art. 116085.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.bmc.2021.116085